Skip to Main Content

2015 Medicare Drug Spending Dashboard

CMS Drug Spending


Main Content

2015 Medicare Drug Spending Dashboard

The 2015 Medicare Drug Spending Dashboard is an online interactive tool that presents drug spending and utilization information on certain Medicare Part B drugs (drugs administered in doctors’ offices and other outpatient settings) and Medicare Part D drugs (drugs patients generally administer themselves). To create this dashboard, CMS identified 80 drugs using 2015 data that met the criteria described below, 40 drugs provided through the Medicare Prescription Drug Program under Part D and 40 drugs administered by physicians and other professionals in the Medicare fee-for-service program under Part B. Products have been selected from each respective program area based on the following criteria: the drug is ranked in the top 15 in terms of total program spending (for either Part B or D); the drug is associated with a high annual per user spending based on claims data analyses (i.e., greater than $10,000 per user) and is ranked in the top 15 by overall program spending (and not already selected by the prior criterion); or the drug is ranked among the top 10 high unit cost increases (and not already selected by the either of the prior two criteria). For additional information on the selection criteria, please see the detailed methodology document available via the link below.

For all drugs included, the tool displays relevant spending, utilization, and trend data and also includes consumer-friendly information on the drug product descriptions, manufacturer(s), and uses. CMS is prohibited from publicly disclosing drug-specific information on manufacturer rebates thus the data used to select Part D drugs do not reflect any manufacturers’ rebates or other price concessions.  However, a high-level summary of 2015 rebate information will be made available at a later date for Part D drugs overall and for the Part D drugs included in this dashboard.

 

2015 Medicare Drug Spending Dashboard Evidence-based Practice Center (EPC) Reports


Access the Detailed Methodology Document.

Download the full underlying data in Excel.

For more information, please see our Fact Sheet.

Inquiries regarding this data can be sent to DrugListInput@cms.hhs.gov